Drugmaker Eli Lilly says its oral, daily GLP-1 pill may offer similar weight loss results as weekly GLP-1 shots. Eli Lilly, the maker of Mounjaro and Zepbound, said Thursday that the company's new ...

Studies have shown that 15-60% of weight loss for patients on GLP-1 medications is lean muscle mass. That means, if a patient loses 50 pounds, they could lose anywhere from 7.5 to 30 pounds of ...

Microdosing GLP-1 drugs is gaining popularity among people seeking to lose weight. The weight loss platform Noom recently launched its compounded GLP-1 microdose injections that claim to promote ...

Eli Lilly, the pharmaceutical company behind GLP-1 injection Zepbound, is working to bring its weight loss drug to the market in pill form. In an Aug. 7 earnings call, Eli Lilly CEO David Ricks ...

GLP-1 receptor agonists, a class of drug used to treat type 2 diabetes, likely trump the widely prescribed metformin for curbing dementia risk in people with the condition, finds the largest study ...